Our patented technology combines two nature-derived biopolymers that self-assemble into a protective layer
View ResultsThis layer deactivates bacteria on contact and prevents their proliferation by stopping them from settling
Antimicrobial activity
Antimicrobial, antiviral, and anti-inflammatory activity
The combination retains individual effects and forms a physically stable coating
Streamlined production process
Safe for human use
Non-drug-based solution
Combats resistant strains
Eco-friendly formulation
Environmentally sustainable
In vitro and in vivo results demonstrating the efficacy of Spartha treatment
Microorganism growth in contact with Spartha coatings - ISO 22196 Test
| Microorganism | Log Reduction in CFU/mL at 24h | Efficacy |
|---|---|---|
| Escherichia coli | Up to 8.11 ± 0.10 | |
| Pseudomonas aeruginosa | Up to 8.43 ± 0.16 | |
| Candida albicans | Up to 5.33 ± 0.35 | |
| Staphylococcus epidermidis | Up to 7.11 ± 0.96 | |
| Staphylococcus aureus | Up to 6.40 ± 0.22 | |
| MRSA | Up to 6.49 ± 0.93 | |
| Enterococcus faecalis | Up to 7.64 ± 0.07 |
Normalized Growth of S. aureus (Logarithmic Reduction in Average Radiance)
Data represents in vitro testing results under controlled conditions. Spartha coating significantly reduces bacterial growth compared to untreated samples.
Continuous innovation for optimal protection
Accelerating coating customization through artificial intelligence
Customized interfaces, Antimicrobial activity, Multifunctional, Safe and durable
Significant reduction in wound closure time
Preventing biofilm formation and developing new molecules
CFU/mL below detection threshold, Reduced bioluminescence on wounds
Spartha treatment sterilization does not alter antibacterial activity
✅ Activity preserved
✅ Activity preserved
✅ Activity preserved
✅ Activity preserved
Our team of experts is here to guide you
Join us in pioneering bio||intelligence for a healthy and sustainable future